Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension
Clinical trial NCT04004000 · TERMINATED
Trial details
- NCT number
- NCT04004000
- Sponsor
- Fulcrum Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-23
- Primary completion
- 2024-10-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.